Off Target Effects of the Atypical Antipsychotic Clozapine Associated with Increased Infection Risk
Offered By: Labroots via YouTube
Course Description
Overview
Explore the off-target effects of clozapine, an atypical antipsychotic medication, and its association with increased infection risk in this 31-minute webinar presented by Dr. Georgios Miliotis. Delve into the growing recognition of antipsychotic medications' link to heightened infection risks, with a particular focus on clozapine, which is used to treat treatment-resistant schizophrenia. Learn about Dr. Miliotis' background as an Assistant Professor in Bacteriology and member of the Antimicrobial Resistance and Microbial Ecology Group. Gain insights into the specific concerns surrounding respiratory infections in patients treated with clozapine and understand the implications for clinical practice and patient care.
Syllabus
Off Target Effects of the Atypical Antipsychotic Clozapine Associated with Increased Infection Risk
Taught by
Labroots
Related Courses
Bacterial Genomes: Antimicrobial Resistance in Bacterial PathogensWellcome Genome Campus via FutureLearn Antimicrobial resistance - theory and methods
Technical University of Denmark (DTU) via Coursera Antimicrobial Stewardship for Africa
The British Society for Antimicrobial Chemotherapy via FutureLearn Bacteria and Chronic Infections
University of Copenhagen via Coursera Bacterial Genomes III: Comparative Genomics using Artemis Comparison Tool (ACT)
Wellcome Genome Campus via FutureLearn